Newcore Gold Ltd. (PCR.V) (CVE:PCR – Get Free Report) Director Barry Johnson Blayne purchased 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 24th. The shares were purchased at an average cost of C$0.31 per share, with a total value of C$15,250.00.
Newcore Gold Ltd. (PCR.V) Price Performance
Shares of Newcore Gold Ltd. (PCR.V) stock traded up C$0.01 on Tuesday, hitting C$0.74. 154,370 shares of the company’s stock traded hands, compared to its average volume of 222,976. Newcore Gold Ltd. has a one year low of C$0.14 and a one year high of C$0.86. The firm’s 50-day moving average price is C$0.74 and its two-hundred day moving average price is C$0.74. The stock has a market capitalization of C$59.16 million and a PE ratio of -185.00.
Newcore Gold Ltd. (PCR.V) Company Profile
Read More
- Five stocks we like better than Newcore Gold Ltd. (PCR.V)
- Top Stocks Investing in 5G Technology
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- What does consumer price index measure?
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- What Are Treasury Bonds?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Newcore Gold Ltd. (PCR.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcore Gold Ltd. (PCR.V) and related companies with MarketBeat.com's FREE daily email newsletter.